Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""azetidines"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 868
Tytuł:
Effectiveness and safety of baricitinib in patients with moderate-to-severe refractory alopecia areata in real world: An open-label, single-center study.
Autorzy:
Bi L; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wang C; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Du Y; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Su T; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.; Department of Dermatology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Zhao M; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Lin X; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Fan W; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Sun W; Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Apr; Vol. 23 (4), pp. 1417-1421. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Alopecia Areata*/drug therapy
Janus Kinase Inhibitors*/adverse effects
Azetidines*
Purines*
Pyrazoles*
Sulfonamides*
Male ; Female ; Humans ; Retrospective Studies ; Immunoglobulin A/therapeutic use
SCR Disease Name:
Diffuse alopecia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
IRF1 Mediates Growth Arrest and the Induction of a Secretory Phenotype in Alveolar Epithelial Cells in Response to Inflammatory Cytokines IFNγ/TNFα.
Autorzy:
Recchia Luciani G; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Barilli A; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Visigalli R; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Sala R; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Dall'Asta V; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Rotoli BM; Laboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 19; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Azetidines*
Cytokines*/metabolism
Purines*
Pyrazoles*
Sulfonamides*
Tumor Necrosis Factor-alpha*/metabolism
Alveolar Epithelial Cells/metabolism ; Cellular Senescence ; Interleukin-6/metabolism ; Phenotype ; A549 Cells ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo.
Autorzy:
Jafarzadeh A; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Pour Mohammad A; Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Khosravi M; Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Amiri S; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Rasouli A; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Keramati H; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Goodarzi A; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Pokaż więcej
Źródło:
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2024 Mar; Vol. 30 (3), pp. e13642.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Vitiligo*/drug therapy
Vitiligo*/pathology
Hypopigmentation*
Purines*
Pyrazoles*
Sulfonamides*
Azetidines*
Thalidomide/*analogs & derivatives
Humans ; Methotrexate/therapeutic use ; Azathioprine/therapeutic use ; Mycophenolic Acid/therapeutic use ; Minocycline/therapeutic use ; Alefacept/therapeutic use ; Cyclosporine/therapeutic use ; Adrenal Cortex Hormones ; Simvastatin/therapeutic use ; Zinc/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways.
Autorzy:
Gurrea-Rubio M; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Wang Q; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Mills EA; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Wu Q; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Pitt D; Department of Neurology, Yale Medicine, New Haven, CT 06473, USA.
Tsou PS; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Fox DA; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Mao-Draayer Y; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Multiple Sclerosis Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 20; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroprotective Agents*/pharmacology
Multiple Sclerosis*/drug therapy
Multiple Sclerosis, Chronic Progressive*/drug therapy
Azetidines*
Benzyl Compounds*
Humans ; Animals ; Rats ; Sphingosine-1-Phosphate Receptors ; Neuroinflammatory Diseases ; Tumor Necrosis Factor-alpha/therapeutic use ; Cell Death
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genomic and Comparative Transcriptomic Analyses Reveal Key Genes Associated with the Biosynthesis Regulation of Okaramine B in Penicillium daleae NBP-49626.
Autorzy:
Wang Y; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Chen L; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Fang W; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Zeng Z; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Wu Z; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Liu F; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Liu X; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Gong Y; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Zhu L; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Wang K; National Biopesticide Engineering Technology Research Centre, Hubei Biopesticide Engineering Research Centre, Key Laboratory of Microbial Pesticides, Ministry of Agriculture and Rural Affairs, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 06; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Penicillium*/metabolism
Azetidines*
Azocines*
Indole Alkaloids*
Gene Expression Profiling ; Genomics/methods
SCR Organism:
Penicillium daleae
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Demodicosis in a Kunekune pig and molecular characterisation of porcine demodectic mites involved: a case report.
Autorzy:
Schwarz L; Department for Farm Animals and Veterinary Public Health, University Clinic for Swine, University of Veterinary Medicine Vienna, Vienna, Austria. .
Herb V; Clinical Unit of Small Animal Surgery, Ophthalmology, Department for Companion Animals and Horses, University Clinic for Small Animals, University of Veterinary Medicine Vienna, Vienna, Austria.; Fachtierärzte Althangrund, Vienna, Austria.
Dürlinger S; Department for Farm Animals and Veterinary Public Health, University Clinic for Swine, University of Veterinary Medicine Vienna, Vienna, Austria.
Martin V; Department for Farm Animals and Veterinary Public Health, University Clinic for Swine, University of Veterinary Medicine Vienna, Vienna, Austria.
Poláková N; Clinical Unit of Internal Medicine Small Animals, Dermatology, Department for Companion Animals and Horses, University Clinic for Small Animals, University of Veterinary Medicine Vienna, Vienna, Austria.
Horvath-Ungerböck C; Clinical Unit of Internal Medicine Small Animals, Dermatology, Department for Companion Animals and Horses, University Clinic for Small Animals, University of Veterinary Medicine Vienna, Vienna, Austria.
Brunthaler R; Department of Pathobiology, Institute of Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.
Knecht C; Department for Farm Animals and Veterinary Public Health, University Clinic for Swine, University of Veterinary Medicine Vienna, Vienna, Austria.
Dippel M; Department for Farm Animals and Veterinary Public Health, University Clinic for Swine, University of Veterinary Medicine Vienna, Vienna, Austria.
Pikalo J; Department of Pathobiology, Institute of Parasitology, University of Veterinary Medicine Vienna, Vienna, Austria.
Ladinig A; Department for Farm Animals and Veterinary Public Health, University Clinic for Swine, University of Veterinary Medicine Vienna, Vienna, Austria.
Joachim A; Department of Pathobiology, Institute of Parasitology, University of Veterinary Medicine Vienna, Vienna, Austria.
Fuehrer HP; Department of Pathobiology, Institute of Parasitology, University of Veterinary Medicine Vienna, Vienna, Austria.
Pokaż więcej
Źródło:
Parasites & vectors [Parasit Vectors] 2024 Jan 24; Vol. 17 (1), pp. 32. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Skin*
Azetidines*
Spiro Compounds*
Swine ; Animals ; Female ; Ambulatory Care Facilities ; Diagnosis, Differential
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigating the Mitoprotective Effects of S1P Receptor Modulators Ex Vivo Using a Novel Semi-Automated Live Imaging Set-Up.
Autorzy:
Ludwig R; Experimental and Clinical Research Center (ECRC), 13125 Berlin, Germany.; Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Malla B; Experimental and Clinical Research Center (ECRC), 13125 Berlin, Germany.; Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Höhrhan M; Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Institute for Medical Immunology, 13353 Berlin, Germany.
Infante-Duarte C; Experimental and Clinical Research Center (ECRC), 13125 Berlin, Germany.; Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Anderhalten L; Experimental and Clinical Research Center (ECRC), 13125 Berlin, Germany.; Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 23; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Fingolimod Hydrochloride*/pharmacology
Azetidines*
Animals ; Mice ; Sphingosine-1-Phosphate Receptors ; Benzyl Compounds
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials.
Autorzy:
Bieber T; Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany.; Christine Kühne - Center for Allergy Research and Education, Davos, Switzerland.
Katoh N; Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Simpson EL; Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.
de Bruin-Weller M; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
Torrelo A; Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Sontag A; Eli Lilly and Company, Indianapolis, IN, USA.
Grond S; Eli Lilly and Company, Indianapolis, IN, USA.
Issa M; Eli Lilly and Company, Indianapolis, IN, USA.
Lu X; TechData Service Company, King of Prussia, PA, USA.
Cardillo T; Eli Lilly and Company, Indianapolis, IN, USA.
Holzwarth K; Eli Lilly and Company, Indianapolis, IN, USA.
Thyssen JP; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2161812.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Azetidines*/adverse effects
Janus Kinase Inhibitors*/adverse effects
Neoplasms*/chemically induced
Adult ; Humans ; Sulfonamides/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Alleviation of isolated nail lichen planus by the JAK1/2 inhibitor Baricitinib: a case report.
Autorzy:
He J; Department of Dermatology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Weng T; Department of Dermatology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Zhu W; Department of Dermatology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Yang Y; Department of Dermatology, The Third Medical Center of the Chinese People's Liberation Army, Beijing, China.
Li C; Department of Dermatology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2274816. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Azetidines*/therapeutic use
Lichen Planus*/drug therapy
Nail Diseases*
Humans ; Janus Kinase 1 ; Purines/therapeutic use ; Male ; Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience.
Autorzy:
Gargiulo L; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Ibba L; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Vignoli CA; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Ferrucci SM; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Mercuri SR; Dermatology and Cosmetology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Malagoli P; Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy.
Marzano AV; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Barbareschi M; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Bianchi VG; Dermatology and Cosmetology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Valenti M; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Costanzo A; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Narcisi A; Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2268764. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Alopecia Areata*/drug therapy
Azetidines*/therapeutic use
Humans ; Purines/therapeutic use
SCR Disease Name:
Diffuse alopecia
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.
Autorzy:
Wu J; Department of Rheumatology Immunology and Allergy, Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, 3333, Binsheng Road, Hangzhou, 310052, China.
Zhou Q; Life Sciences Institute, Zhejiang University, Hangzhou, China.
Zhou H; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lu M; Department of Rheumatology Immunology and Allergy, Children's Hospital, School of Medicine, Zhejiang University, National Clinical Research Center for Child Health, 3333, Binsheng Road, Hangzhou, 310052, China. .
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2023 Oct 26; Vol. 21 (1), pp. 131. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Azetidines*/therapeutic use
Lung Diseases, Interstitial*/etiology
Lung Diseases, Interstitial*/genetics
Vascular Diseases*/drug therapy
Adult ; Child, Preschool ; Female ; Humans ; Inflammation/drug therapy ; Janus Kinase 1/genetics ; Pyrazoles/therapeutic use ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
Autorzy:
Reguiai Z; Department of Dermatology, Polyclinique Courlancy, Reims-Bezannes, France. .
Becherel PA; Dermatology and Clinical Immunology Unit, Antony Hospital, Antony, France.
Perrot JL; Department of Dermatology, CHU Saint Etienne, Saint-Etienne, France.
Fougerousse AC; Department of Dermatology, Hôpital d'Instruction des Armées Begin, Saint Mandé, France.
Begon E; Department of Dermatology, Centre hospitalier René Dubos, Pontoise, France.
Poreaux C; Centre médical Stanislas-Nancy, Nancy, France.
Boulard C; Department of Dermatology, Centre hospitalier du Havre, Le Havre, France.
Chaby G; Department of Dermatology, CHU Amiens-Picardie, Amiens, France.
Fite C; Department of Dermatology, Hôpital Paris Saint Joseph, Paris, France.
Zaraa I; Department of Dermatology, Hôpital Paris Saint Joseph, Paris, France.
Lons-Danic D; Department of Dermatology, Hôpital Paris Saint Joseph, Paris, France.
Liegeon AL; Department of Dermatology, Centre hospitalier régional Metz-Thionville, Thionville, France.
Parier J; Centre de Santé Sabouraud, Hôpital Saint-Louis, Paris, france; Cabinet Médical, Saint-Maur-des-Fossés, France.
Quiles-Tsimaratos N; Department of Dermatology, Hôpital Saint Joseph, Marseille, France.
David L; Department of Dermatology, Hôpital Saint Joseph, Marseille, France.
Maccari F; Department of Dermatology, Hôpital d'Instruction des Armées Begin, Saint Mandé, France; Department of Dermatology, Hôpital Saint Joseph, Marseille, France.
Pokaż więcej
Źródło:
Acta dermato-venereologica [Acta Derm Venereol] 2023 Oct 06; Vol. 103, pp. adv14153. Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatitis, Atopic*/diagnosis
Dermatitis, Atopic*/drug therapy
Azetidines*/adverse effects
Humans ; Quality of Life ; Registries ; Treatment Outcome ; Severity of Illness Index ; Double-Blind Method
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis.
Autorzy:
Koh YG; Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Han HS; Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Gyeonggi-do, Republic of Korea.
Seok J; Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Choi SY; Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Gyeonggi-do, Republic of Korea.
Li K; Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Kim BJ; Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Yoo KH; Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong-si, Gyeonggi-do, Republic of Korea.
Pokaż więcej
Źródło:
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2023 Aug; Vol. 29 (8), pp. e13425.
Typ publikacji:
Letter
MeSH Terms:
Azetidines*/therapeutic use
Humans ; Purines ; Pyrazoles/therapeutic use ; Alopecia/drug therapy
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Length-Dependent Transition from Extended to Folded Shapes in Short Oligomers of an Azetidine-Based α-Amino Acid: The Critical Role of NH···N H-Bonds.
Autorzy:
Liu D; Université Paris-Saclay, CNRS, ICMMO, 91400 Orsay, France.
Bardaud JX; Université Paris-Saclay, CEA, CNRS, LIDYL, 91191 Gif-sur-Yvette, France.
Imani Z; Université Paris-Saclay, CNRS, ICMMO, 91400 Orsay, France.
Robin S; Université Paris-Saclay, CNRS, ICMMO, 91400 Orsay, France.; Université Paris Cité, Faculté de Pharmacie, 75006 Paris, France.
Gloaguen E; Université Paris-Saclay, CEA, CNRS, LIDYL, 91191 Gif-sur-Yvette, France.
Brenner V; Université Paris-Saclay, CEA, CNRS, LIDYL, 91191 Gif-sur-Yvette, France.
Aitken DJ; Université Paris-Saclay, CNRS, ICMMO, 91400 Orsay, France.
Mons M; Université Paris-Saclay, CEA, CNRS, LIDYL, 91191 Gif-sur-Yvette, France.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Jun 28; Vol. 28 (13). Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:
Journal Article
MeSH Terms:
Amino Acids*/chemistry
Azetidines*
Proteins/chemistry ; Peptides/chemistry ; Protein Structure, Secondary ; Hydrogen Bonding
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of Baricitinib in Patients with Refractory Adult-Onset Still's Disease.
Autorzy:
Sun Z; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.; Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin, 300052, People's Republic of China.
Li R; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.; Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin, 300052, People's Republic of China.
Wang Y; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.; Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin, 300052, People's Republic of China.
Han F; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.; Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin, 300052, People's Republic of China.
Wei W; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.; Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin, 300052, People's Republic of China.
Li X; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China. .; Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin, 300052, People's Republic of China. .
Pokaż więcej
Źródło:
Drugs in R&D [Drugs R D] 2023 Jun; Vol. 23 (2), pp. 109-120. Date of Electronic Publication: 2023 Apr 03.
Typ publikacji:
Journal Article
MeSH Terms:
Still's Disease, Adult-Onset*/diagnosis
Still's Disease, Adult-Onset*/drug therapy
Azetidines*/adverse effects
Adult ; Humans ; Female ; Prospective Studies ; Purines/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of the efficacy of Simparica Trio in the prevention of the transmission of Babesia canis by infected Dermacentor reticulatus to dogs.
Autorzy:
Borowski S; Zoetis Belgium SA, Veterinary Medicine Research & Development, Mercuriusstraat 20, 1930, Zaventem, Belgium. .
Viljoen A; Clinvet International, Uitzich Road, Bainsvlei, Bloemfontein, 9338, South Africa.
D'Hanis L; Zoetis Belgium SA, Veterinary Medicine Research & Development, Mercuriusstraat 20, 1930, Zaventem, Belgium.
Mahabir S; Zoetis, Veterinary Medicine Research & Development, 333 Portage Street, Kalamazoo, MI, 49007, USA.
Geurden T; Zoetis Belgium SA, Veterinary Medicine Research & Development, Mercuriusstraat 20, 1930, Zaventem, Belgium.
Pokaż więcej
Źródło:
Parasites & vectors [Parasit Vectors] 2024 Feb 02; Vol. 17 (1), pp. 51. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Randomized Controlled Trial, Veterinary; Journal Article
MeSH Terms:
Acaricides*/therapeutic use
Babesia*/genetics
Babesiosis*/prevention & control
Dog Diseases*/drug therapy
Dog Diseases*/prevention & control
Animals ; Dogs ; Administration, Oral ; Azetidines ; Dermacentor ; Macrolides ; Pyrantel/therapeutic use ; Spiro Compounds ; Tick Infestations/drug therapy ; Tick Infestations/prevention & control ; Tick Infestations/veterinary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rapid improvement of refractory generalized granuloma annulare with the Janus kinase inhibitor baricitinib in two patients.
Autorzy:
Kim D; Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
Kang HY; Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Mar 22; Vol. 48 (4), pp. 375-376.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Granuloma Annulare*/drug therapy
Janus Kinase Inhibitors*/therapeutic use
Azetidines*/therapeutic use
Humans ; Sulfonamides/therapeutic use
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A case of Sézary syndrome in a patient during treatment with baricitinib for seronegative rheumatoid arthritis.
Autorzy:
Saito K; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Shimauchi T; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kageyama R; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Furukawa S; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Suzuki N; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Ginoza A; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Moriki M; Department of Dermatology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Ito T; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Honda T; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Mar 22; Vol. 48 (4), pp. 391-393.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Sezary Syndrome*/drug therapy
Arthritis, Rheumatoid*/drug therapy
Azetidines*/adverse effects
Skin Neoplasms*/drug therapy
Antirheumatic Agents*/therapeutic use
Humans ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers.
Autorzy:
Younis IR; Gilead Sciences, Inc., Foster City, California, USA.
Kirby BJ; Gilead Sciences, Inc., Foster City, California, USA.
Billin AN; Gilead Sciences, Inc., Foster City, California, USA.
Xiao D; Gilead Sciences, Inc., Foster City, California, USA.
Song Q; Gilead Sciences, Inc., Foster City, California, USA.
Watkins TR; Gilead Sciences, Inc., Foster City, California, USA.
Othman AA; Gilead Sciences, Inc., Foster City, California, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Mar; Vol. 16 (3), pp. 536-547. Date of Electronic Publication: 2023 Jan 15.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/drug therapy
Azetidines*
Humans ; Healthy Volunteers ; Isonicotinic Acids ; Bile Acids and Salts/adverse effects ; Double-Blind Method ; Dose-Response Relationship, Drug
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of baricitinib in patients with refractory alopecia areata.
Autorzy:
Wang Y; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Liu T; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Li S; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Tang S; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Lin P; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Ding Y; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Sun Q; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Zhu D; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Qiao J; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Fang H; Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2022 Dec; Vol. 35 (12), pp. e15845. Date of Electronic Publication: 2022 Oct 18.
Typ publikacji:
Letter; Comment
MeSH Terms:
Alopecia Areata*/drug therapy
Azetidines*/adverse effects
Humans ; Purines/adverse effects
SCR Disease Name:
Diffuse alopecia
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 868

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies